CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement.

Tarun Kumar Suvvari,Vinay Suresh,Krish Patel,Ananya Arora,Aman Bhonsale,Rahul Jena,Vivek Sanker

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine（2023）

引用 0|浏览3

暂无评分

摘要

•CAR-T cell therapy has shown significant clinical responses in malignancies like B-cell leukaemia and lymphoma.•There are is very little research and limited number (just 2) trials conducted on CAR T-cell therapy in the Indian subcontinent. This is a cause for concern, given the proven efficacy of the therapy.•High cost, technical requirements, funding challenges, and lack of a complex workforce are limiting factors for conducting CAR-T cell therapy clinical trials in India.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要